160 related articles for article (PubMed ID: 31750445)
1. A rare case of perimyocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia.
Ben El Makki A; Mahtat EM; Kheyi J; Bouzelmat H; Chaib A
Med Pharm Rep; 2019 Oct; 92(4):418-420. PubMed ID: 31750445
[TBL] [Abstract][Full Text] [Related]
2. Reversible Symptomatic Myocarditis Induced by All-Trans Retinoic Acid Administration during Induction Treatment of Acute Promyelocytic Leukemia: Rare Cardiac Manifestation as a Retinoic Acid Syndrome.
Choi S; Kim HS; Jung CS; Jung SW; Lee YJ; Rheu JK; Jo JR; Lee NH
J Cardiovasc Ultrasound; 2011 Jun; 19(2):95-8. PubMed ID: 21860725
[TBL] [Abstract][Full Text] [Related]
3. All-
Karakulak UN; Aladag E; Hazirolan T; Ozer N; Demiroglu H; Goker H
JACC Case Rep; 2020 Nov; 2(13):2101-2106. PubMed ID: 34317116
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.
Holmes D; Vishnu P; Dorer RK; Aboulafia DM
Case Rep Oncol Med; 2012; 2012():313057. PubMed ID: 22701192
[TBL] [Abstract][Full Text] [Related]
6. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
7. All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia.
Bapna A; Nair R; Tapan KS; Nair CN; Kadam P; Gladstone B; Advani SH
Pediatr Hematol Oncol; 1998; 15(3):243-8. PubMed ID: 9615322
[TBL] [Abstract][Full Text] [Related]
8. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
9. All-Trans Retinoic Acid-Induced Ototoxicity during Chemotherapy in Pediatric Acute Promyelocytic Leukemia.
Lee JH; Lee JH; Lee JM
Children (Basel); 2021 Jan; 8(1):. PubMed ID: 33419229
[TBL] [Abstract][Full Text] [Related]
10. Bradycardia during Induction Therapy with All-
Chen PZ; Wu YJ; Wu CC; Wang YW
Case Rep Hematol; 2018; 2018():4938797. PubMed ID: 29984015
[TBL] [Abstract][Full Text] [Related]
11. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].
Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T
Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
Özpolat B
Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
15. Genital ulcer development in patients with acute promyelocytic leukaemia treated with all-trans retinoic Acid: a case series.
Al Huneini M; Wasim F; Al Farsi K; Al-Khabori M; Al Kindi S
Oman Med J; 2013 May; 28(3):207-9. PubMed ID: 23772289
[TBL] [Abstract][Full Text] [Related]
16. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
Xu SN; Chen JP; Liu JP; Xia Y
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.
Jeddi R; Kacem K; Ben Neji H; Mnif S; Gouider E; Aissaoui L; Ben Amor R; Ben Lakhal R; Ben Abid H; Belhadjali Z; Meddeb B
Hematology; 2008 Jun; 13(3):142-6. PubMed ID: 18702871
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.
Advani SH; Nair R; Bapna A; Gladstone B; Kadam P; Saikia TK; Parekh PM; Gopal R; Nair CN
Am J Hematol; 1999 Feb; 60(2):87-93. PubMed ID: 9929098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
